The inside story on DNA 'vaccine' supply chains—Part 2

Not getting any better

Part 1 ended thus…

“Part 2 will be along tomorrow, and it doesn’t get any better…”

…so sorry for the delay, but I've been travelling for an interview with James Wells, who does documentaries on the vaccine damaged, and then to Parliament for the All Party Parliamentary Group session on Vaccine Damage. More to come on that next week.

In Part 2, we continue with the shocking standards of quality in the SARS-CoV-2 supply chains, primarily down to lack of oversight from the tiny companies supposedly in charge of everything. This time it’s BioTech’s own facility, hastily purchased from Novartis in the nick of time, or was it?

BioNTech’s COVID-19 Vaccine Manufacturing Facility, Marburg

This article in PHARMACEUTICAL TECHNOLOGY tells us a lot: